Navigenics - Our advisory boards

David Agus is a prostate cancer specialist who directs the Spielberg Family Center for Applied Proteomics at Cedars-Sinai Medical Center in Los Angeles. He and his colleagues aim to understand the underpinnings of individual variation and use that information to predict treatment responsiveness and improve patient care.

Carlos Camargo is an emeritus clinical professor of medicine at Stanford University Medical Center, where he has been on the faculty for more than 40 years. He is the director of the medical history course and a three-time recipient of the Kaiser Award for Excellence in Teaching.

Daniel Federman is senior dean for alumni relations and clinical teaching at Harvard Medical School, where he has been on the faculty for more than 40 years. An endocrinologist by training, Dr. Federman maintains an active clinical practice in Boston.

Bruce E. Landon is associate professor of health care, Harvard Medical School, and associate professor of medicine, Beth Israel Deaconess Medical Center. His research interests include assessing the impact of different characteristics of physician and health care organizations on the provision of health care.

Dr. Nierenberg has been the personal physician to many of Silicon Valley's CEOs, venture capitalists and lawyers, as well as prominent national and international figures. He has been mentioned frequently in local and national publications as a top internist. Dr. Nierenberg practiced internal medicine in Palo Alto and Menlo Park, California, for 30 years, serves as an emeritus clinical professor of medicine at Stanford University and consults in the legal and venture capital arena. Dr. Nierenberg is also medical advisor to Shalon Ventures, a company developing medical devices.

Jeffrey Trent is president and scientific director of the Translational Genomics Research Institute, whose mission is to make and translate genomic discoveries into advances in human health. Prior to forming TGen, Dr. Trent served for 10 years at the National Institutes of Health, where he founded and directed the laboratory division in charge of coordinating and finalizing the Human Genome Project.

David Botstein and colleagues proposed a method in 1980 for mapping genes that laid the groundwork for the Human Genome Project. He is director of the Lewis-Sigler Institute for Integrative Genomics and Anthony B. Evnin professor of genomics at Princeton University and a member of the National Academy of Sciences.

Isaac Kohane is an associate professor at Harvard Medical School, where he uses genomics and computer science to study cancer and the development of the brain, with emphasis on autism. He has developed computer systems to allow hospitals to be used as "living laboratories" to study the genetic basis of disease while preserving patient privacy.

Nicholas J. Schork is Director of Biostatistics and Bioinformatics at the Scripps Translational Sciences Institute and Professor, Molecular and Experimental Medicine at The Scripps Research Institute. His research focuses primarily on understanding the genetic basis of complex traits and diseases.

Dietrich Stephan is a human geneticist on the faculty of the Translational Genomics Research Institute and chairman of the National Institutes of Health Neuroscience Microarray Consortium. He has identified genes that predispose to disorders such as autism, exercise-induced heart attacks and sudden infant death syndrome, and contributed to understanding a multitude of common disorders such as Alzheimer's disease.

Spencer Wells is a leading population geneticist, the director of the Genographic Project and a National Geographic Explorer-in-Residence. A scientist, author and documentary filmmaker, he has dedicated much of his career to studying humankind's family tree and closing the gaps in our knowledge of human migration.

Robin Bennett is a leader in the genetic counseling field, including having served as president of the National Society of Genetic Counselors. She is a senior genetic counselor and clinical assistant professor at the University of Washington.

Peggy G. Conrad is a practicing genetic counselor who helped establish the University of California-San Francisco Familial Gastrointestinal Cancer Program.

Elissa Levin helped pioneer one of the first direct-to-consumer genetic testing programs, providing testing, education and counseling services for specific medical conditions.

Kelly Ormond directs the new Human Genetics and Genetic Counseling Training Program at Stanford University. She is a past president of the National Society of Genetic Counselors.

Greg Simon is president of FasterCures/The Center for Accelerating Medical Solutions. FasterCures aims to discover and promote ways to accelerate new medical treatments. Previously, Mr. Simon was the chief domestic policy advisor to Vice President Al Gore from 1993 to 1997.

Kathi E. Hanna has more than 25 years of experience as an analyst, writer and editor specializing in biomedical research policy. She has served as a consultant to a wide range of public and private organizations on matters related to bioethics and regulatory and ethical compliance in research.

Paul Slovic a founder and president of Decision Research, studies human judgment, decision-making and risk analysis. He and his colleagues have developed methods to describe risk perceptions and measure their impacts on individuals, industry and society.

John Sadler has more than 15 years' experience as a multidisciplinary technology executive. His accomplishments include designing and delivering GenVault's archive for genetic material. He led the architecture and design of Affymetrix GeneChip instrument systems at Agilent as well as Agilent's second-generation gene array system and associated informatics.